PHARMAVITE H-1B Visa Sponsorship & Salary Data

The median H-1B salary at PHARMAVITE is $120,000, based on 59 certified filings from FY 2020 to FY 2026. This is equal to the national H-1B median salary of $120,000. Compensation at PHARMAVITE reflects their market positioning, with entry-level roles starting around $102,193 and senior positions reaching $180,300 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at PHARMAVITE range from $90,120 at the 10th percentile to $180,300 at the 90th percentile, showing a $90,180 spread across experience levels and roles. The 25th percentile is $102,193 and the 75th percentile is $144,000.

Yes, PHARMAVITE actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 60 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 59 certified applications and a 0% denial rate, PHARMAVITE maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), PHARMAVITE filed 1 H-1B applications, with 1 certified and 0 denied. Over 7 years of data, PHARMAVITE has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

PHARMAVITE's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 60 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating PHARMAVITE as a potential H-1B sponsor.

This is an excellent approval rate, indicating PHARMAVITE has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

PHARMAVITE sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 59 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles PHARMAVITE most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at PHARMAVITE:

The most frequently sponsored role is Research Scientist with 4 filings at a median salary of $108,000. This is followed by Manager, Quality Control (4 filings) and Senior Business Analyst.

PHARMAVITE's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where PHARMAVITE sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top PHARMAVITE H-1B locations:

The largest H-1B hub for PHARMAVITE is West Hills, CA with 31 filings at a median salary of $125,100. The highest-paying location is West Lafayette, IN at $190,000 median. Salaries range from $99,000 to $190,000 across office locations.

PHARMAVITE's median H-1B salary has increased by +77% from FY 2020 ($107,150) to FY 2026 ($190,000). Tracking salary trends over time reveals how PHARMAVITE adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at PHARMAVITE.

Year-by-year breakdown:

• FY 2022: $120,000 (9 certified)
• FY 2023: $125,000 (11 certified)
• FY 2024: $125,100 (10 certified)
• FY 2025: $134,000 (5 certified)
• FY 2026: $190,000 (1 certified)

This 77% growth reflects strong compensation adjustments at PHARMAVITE, keeping pace with market demands for H-1B talent.

PHARMAVITE primarily files H-1B applications at Wage Level IV, accounting for 36% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making PHARMAVITE's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 88% of positions at Level II or higher, PHARMAVITE typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

PHARMAVITE's median H-1B salary of $120,000 is equal to the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating PHARMAVITE's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare PHARMAVITE's offerings with similar companies in your field for a more accurate assessment.

PHARMAVITE's H-1B salaries are competitive with industry averages. The 59 total filings indicate active H-1B sponsorship.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. PHARMAVITE's higher proportion of Level III-IV positions (66%) may benefit from wage-based lottery prioritization.

With 59 certified filings, PHARMAVITE invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.